Less-Frequent Injected Drug Works in Wet Macular Degeneration

Regeneron Pharmaceuticals Inc's treatment for wet macular degeneration was as effective and safe in two late-stage trials as Roche Holding AG's blockbuster Lucentis, with half the number of eye injections.
Reuters Health Information

Full Story →